Tag: Concert Pharmaceuticals

Finance

Active Watch List: The Walt Disney Company (NYSE:DIS), Pfizer Inc. (NYSE:PFE), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Concert Pharmaceuticals (NASDAQ:CNCE), ITT Corporation (NYSE:ITT)

The Walt Disney Company (NYSE:DIS) in South East Asia (SEA) on 10 October announced changes to its management team to position for rapid growth in the film and media distribution landscape in the region. Amit Malhotra, previously General Manager Disney Media Distribution and Media+ becomes General Manager, Studio Entertainment SEA and will oversee all the Studio businesses (Theatrical, In-Home, Live Events and Stage Plays) in … Continue reading Active Watch List: The Walt Disney Company (NYSE:DIS), Pfizer Inc. (NYSE:PFE), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Concert Pharmaceuticals (NASDAQ:CNCE), ITT Corporation (NYSE:ITT)

Mark DeFrance
Finance

Shining on Major News : TIBCO Software (NASDAQ:TIBX), Youku Tudou (NYSE:YOKU), Apple Inc. (NASDAQ:AAPL), Concert Pharmaceuticals (NASDAQ:CNCE), KB Financial Group, Inc. (NYSE:KB),

TIBCO Software Inc. (NASDAQ:TIBX) was gaining Wednesday following reports that private equity firms are competing to buy the business software company. Vista Equity Partners and Thomas Bravo are a part of a small group of private equity firms vying for the opportunity to acquire Tibco, according to Reuters. TIBCO Software Inc. (NASDAQ:TIBX) belongs to Technology sector. Its net profit margin is 7.30% and weekly performance … Continue reading Shining on Major News : TIBCO Software (NASDAQ:TIBX), Youku Tudou (NYSE:YOKU), Apple Inc. (NASDAQ:AAPL), Concert Pharmaceuticals (NASDAQ:CNCE), KB Financial Group, Inc. (NYSE:KB),

Kevin Long
Finance

Active Stocks : Halcon Resources (NYSE:HK), Concert Pharmaceuticals(NASDAQ:CNCE), Eastman Chemical (NYSE:EMN), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Tech Data Corp. (NASDAQ:TECD)

Halcon Resources Corp (NYSE:HK) last released its earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.04 by $0.03. The company had revenue of $327.10 million for the quarter, compared to the consensus estimate of $303.63 million. During the same quarter last year, the company posted $0.04 earnings per share. Halcon Resources … Continue reading Active Stocks : Halcon Resources (NYSE:HK), Concert Pharmaceuticals(NASDAQ:CNCE), Eastman Chemical (NYSE:EMN), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Tech Data Corp. (NASDAQ:TECD)

Ryan Holtz
Finance

Stocks in News: American International Group (NYSE:AIG), Concert Pharmaceuticals (NASDAQ:CNCE), Deluxe (NYSE:DLX), Arctic Cat Inc. (NASDAQ:ACAT), PS Business Parks (NYSE:PSB)

On 4 AUG American International Group, Inc. (NYSE:AIG) declared a quarterly dividend on Monday. Shareholders of record on Thursday, September 11th will be given a dividend of 0.125 per share on Thursday, September 25th. This represents a $0.50 dividend on an annualized basis and a yield of 0.96%. American International Group, Inc. (NYSE:AIG) belongs to Financial sector. Its net profit margin is 13.00% and weekly … Continue reading Stocks in News: American International Group (NYSE:AIG), Concert Pharmaceuticals (NASDAQ:CNCE), Deluxe (NYSE:DLX), Arctic Cat Inc. (NASDAQ:ACAT), PS Business Parks (NYSE:PSB)

Jayne Crisman
Finance

Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

BMO Capital Markets boosted their price target on shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) from $21.00 to $34.00 in a research note issued on Monday. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 34.44% from the stock’s previous close. Applied Genetic Technologies Corp (NASDAQ:AGTC) stock performance was 7.57% in last session … Continue reading Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

Kristen Barton
Finance

Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Insmed Incorporated (NASDAQ:INSM) on May 13, 2014 announces that multiple posterpresentations reporting data on ARIKAYCE(TM), or liposomal amakacinfor inhalation, for the treatment of Pseudomonas aeruginosainfections in cystic fibrosis (CF) patients and for the treatment ofpatients with treatment-resistant nontuberculous mycobacterial (NTM)lung infections will be presented at the American Thoracic SocietyAnnual Meeting 2014, taking place May 16-21 in San Diego, California. Insmed Incorporated (NASDAQ:INSM) stock performance was … Continue reading Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Kevin Long